|
ABI2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.652430E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.330580E-01 |
| Normal-vs-Stage2 |
1.705620E-02 |
| Normal-vs-Stage3 |
6.206700E-04 |
| Normal-vs-Stage4 |
1.238550E-03 |
| Stage1-vs-Stage2 |
1.804250E-01 |
| Stage1-vs-Stage3 |
1.119950E-02 |
| Stage1-vs-Stage4 |
1.806070E-02 |
| Stage2-vs-Stage3 |
6.268400E-01 |
| Stage2-vs-Stage4 |
6.442600E-01 |
| Stage3-vs-Stage4 |
9.875000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.241500E-03 |
| Normal-vs-AfricanAmerican |
8.960000E-01 |
| Normal-vs-Asian |
1.214440E-01 |
| Caucasian-vs-AfricanAmerican |
5.117600E-02 |
| Caucasian-vs-Asian |
3.326000E-01 |
| AfricanAmerican-vs-Asian |
2.650800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.827950E-02 |
| Normal-vs-Female |
2.265700E-02 |
| Male-vs-Female |
7.983200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.253600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.197600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.810770E-04 |
| Normal-vs-Age(81-100Yrs) |
2.007700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.766100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.836400E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.152620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.044590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.984400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.241200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.262700E-03 |
| Classical-VS-Follicular |
1.117320E-03 |
| Classical-VS-Other |
6.405600E-01 |
| Classical-VS-Normal |
1.856050E-01 |
| Tall-VS-Follicular |
5.907600E-01 |
| Tall-VS-Other |
3.425400E-01 |
| Tall-VS-Normal |
6.847300E-04 |
| Follicular-VS-Other |
5.692600E-01 |
| Follicular-VS-Normal |
1.177640E-03 |
| Other-VS-Normal |
3.206600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.657800E-03 |
| Normal-vs-N1 |
5.419200E-03 |
| N0-vs-N1 |
7.977600E-01 |
|
|
